Bristol-Myers Squibb Company

Organization

New York, NY, US

Ticker Symbols

NYSE:BMY

PHARMACEUTICAL PREPARATIONS
Business Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
Mailing Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
State Location
NY
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Metabolic enzyme activity and disulfide bond reduction during prote...
- Patent number 12,325,875
- Issue date Jun 10, 2025
- Bristol-Myers Squibb Company
- Anthony Joseph Cura
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for regenerating chromatography resins
- Patent number 12,325,843
- Issue date Jun 10, 2025
- Bristol-Myers Squibb Company
- James Angelo
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Grant
Substituted amide compounds useful as farnesoid X receptor modulators
- Patent number 12,319,676
- Issue date Jun 3, 2025
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of AAV therapy
- Patent number 12,312,395
- Issue date May 27, 2025
- Bristol-Myers Squibb Company
- Uma Kavita
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies against TIM3 and uses thereof
- Patent number 12,312,403
- Issue date May 27, 2025
- Bristol-Myers Squibb Company
- Xiao Min Schebye
- G01 - MEASURING TESTING
Information Patent Grant
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inh...
- Patent number 12,304,916
- Issue date May 20, 2025
- Bristol-Myers Squibb Company
- Saleem Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4...
- Patent number 12,304,914
- Issue date May 20, 2025
- Bristol-Myers Squibb Company
- Hong Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody comprising a glutamine-containing light chain C-terminal e...
- Patent number 12,290,570
- Issue date May 6, 2025
- Bristol-Myers Squibb Company
- Pavel Strop
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Galectin-3 inhibitors
- Patent number 12,291,522
- Issue date May 6, 2025
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-...
- Patent number 12,291,517
- Issue date May 6, 2025
- Bristol-Myers Squibb Company
- Daniel Richard Roberts
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,286,424
- Issue date Apr 29, 2025
- Bristol-Myers Squibb Company
- Prasada Rao Jalagam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
- Patent number 12,286,428
- Issue date Apr 29, 2025
- Bristol-Myers Squibb Company
- Satheesh Kesavan Nair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use th...
- Patent number 12,281,085
- Issue date Apr 22, 2025
- Immunome, Inc.
- Matti Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indicating differences in and reconciling data stored in disparate...
- Patent number 12,282,492
- Issue date Apr 22, 2025
- Bristol-Myers Squibb Company
- Sahith Doppalapudi
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Pyrrolidinone derivatives as formyl peptide 2 receptor agonists
- Patent number 12,281,108
- Issue date Apr 22, 2025
- Bristol-Myers Squibb Company
- Nicholas R. Wurtz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,275,719
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,275,720
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Prasada Rao Jalagam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indazole carboxamides as kinase inhibitors
- Patent number 12,275,721
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Jie Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,275,718
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Jacob Swidorski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of Galectin-3
- Patent number 12,269,819
- Issue date Apr 8, 2025
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of a cyclic dinucleotide
- Patent number 12,269,840
- Issue date Apr 8, 2025
- Bristol-Myers Squibb Company
- Michael Anthony Schmidt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding modified FGF-21 polypeptides, vectors and ce...
- Patent number 12,247,058
- Issue date Mar 11, 2025
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 12,241,065
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Amide-substituted heterocyclic compounds for the treatment of condi...
- Patent number 12,240,840
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Steven H. Spergel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of controlling the pink color generated during antibody manu...
- Patent number 12,241,107
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Cheng Du
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of decreasing the galactose content of a recombinant glycop...
- Patent number 12,234,483
- Issue date Feb 25, 2025
- Bristol-Myers Squibb Company
- Jun Tian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Piston valving for serially connectable drug modules of a combinato...
- Patent number 12,233,028
- Issue date Feb 25, 2025
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 12,227,496
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FGF-21 formulations
- Patent number 12,226,451
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Thomas Palm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
- Patent number 12,227,575
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Sean E. Doyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF
- Publication number 20250188463
- Publication date Jun 12, 2025
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRANSIENT EXPRESSION OF THERAPEUTIC PROTEINS
- Publication number 20250188152
- Publication date Jun 12, 2025
- Bristol-Myers Squibb Company
- Kitty AGARWAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY FOR COLORECTAL CARCINOMA
- Publication number 20250179174
- Publication date Jun 5, 2025
- Bristol-Myers Squibb Company
- Rebecca Anne MOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED IMIDAZOPYRIDINYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9
- Publication number 20250177363
- Publication date Jun 5, 2025
- Bristol-Myers Squibb Company
- David S. Yoon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...
- Publication number 20250179140
- Publication date Jun 5, 2025
- Bristol-Myers Squibb Company
- Mary STRUTHERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS
- Publication number 20250171538
- Publication date May 29, 2025
- Bristol-Myers Squibb Company
- Anke KLIPPEL
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF PRODUCING RECOMBINANT PROTEINS
- Publication number 20250171732
- Publication date May 29, 2025
- Bristol-Myers Squibb Company
- Jianlin XU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Machine-Learning Models for Prognosing Outcomes For Hypertrophic Ca...
- Publication number 20250174357
- Publication date May 29, 2025
- Bristol-Myers Squibb Company
- Arnaud Bastien
Information Patent Application
SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9
- Publication number 20250163054
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- David S. Yoon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TR...
- Publication number 20250163155
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20250163004
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Steven H. Spergel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC IMMUNOMODULATORS
- Publication number 20250163104
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Jennifer X. QIAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS INHIBITORS
- Publication number 20250163046
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Brian Edward FINK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Their Use for Treatment of Hemoglobinopathies
- Publication number 20250163025
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Thomas J. Cummins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A...
- Publication number 20250163152
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Alan J. KORMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METH...
- Publication number 20250154132
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Victor W. Rosso
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOKINE PROFILING ANALYSIS
- Publication number 20250155451
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Benedetto FARSACI
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANT...
- Publication number 20250152708
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Lori S. BURTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO MANIPULATE QUALITY ATTRIBUTES OF POLYPEPTIDES PRODUCED I...
- Publication number 20250154470
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Jun Tian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBO...
- Publication number 20250154257
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Faith NATHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY
- Publication number 20250154258
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Marina TSCHAIKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN...
- Publication number 20250154274
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Vladimir CORIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS INHIBITORS
- Publication number 20250154148
- Publication date May 15, 2025
- Bristol-Myers Squibb Company
- Brian Edward FINK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC PEPTIDES USEFUL AS MODULATORS OF TNF ALPHA
- Publication number 20250145665
- Publication date May 8, 2025
- Bristol-Myers Squibb Company
- Yong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RENAL CELL CARCINOMA
- Publication number 20250145712
- Publication date May 8, 2025
- Bristol-Myers Squibb Company
- Jason Samuel SIMON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS
- Publication number 20250145590
- Publication date May 8, 2025
- Bristol-Myers Squibb Company
- KHEHYONG NGU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY
- Publication number 20250145713
- Publication date May 8, 2025
- Bristol-Myers Squibb Company
- Robin EDWARDS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
- Publication number 20250134996
- Publication date May 1, 2025
- Bristol-Myers Squibb Company
- Benedetto FARSACI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF
- Publication number 20250136988
- Publication date May 1, 2025
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INDICATING DIFFERENCES IN AND RECONCILING DATA STORED IN DISPARATE...
- Publication number 20250139123
- Publication date May 1, 2025
- Bristol-Myers Squibb Company
- Sahith DOPPALAPUDI
- G06 - COMPUTING CALCULATING COUNTING

Trademarklast 30 trademarks

Information Trademark
99169291 - OPDUALAG QSONI
- Serial number 99169291
- Filing date May 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165576 - OPDUALAG QSOVE
- Serial number 99165576
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165581 - OPDUALAG QUFECTO
- Serial number 99165581
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165591 - OPDUALAG QFECTO
- Serial number 99165591
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165552 - QSISTEN
- Serial number 99165552
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165553 - QSONI
- Serial number 99165553
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165556 - OPDUALAG QSIST
- Serial number 99165556
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165548 - QBYON
- Serial number 99165548
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165550 - OPDUALAG QSISTEN
- Serial number 99165550
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165602 - OPDUALAG QLESK
- Serial number 99165602
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165606 - OPDUALAG QBERI
- Serial number 99165606
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165539 - OPDUALAG QBYON
- Serial number 99165539
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165559 - OPDUALAG QMINSO
- Serial number 99165559
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165578 - QSOVE
- Serial number 99165578
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165585 - QUFECTO
- Serial number 99165585
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165596 - OPDUALAG QVEMI
- Serial number 99165596
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165609 - OPDUALAG QBEVRI
- Serial number 99165609
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165598 - QVEMI
- Serial number 99165598
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165557 - QSIST
- Serial number 99165557
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165561 - QMINSO
- Serial number 99165561
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165564 - OPDUALAG QBYOND
- Serial number 99165564
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165568 - QBYOND
- Serial number 99165568
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165594 - QFECTO
- Serial number 99165594
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99138469 - AXTEMGO
- Serial number 99138469
- Filing date Apr 15, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99138479 - VYMPOWRI
- Serial number 99138479
- Filing date Apr 15, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99138465 - AMEPTLII
- Serial number 99138465
- Filing date Apr 15, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99138475 - UPCLIXIA
- Serial number 99138475
- Filing date Apr 15, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99126617 - MIIZOEE
- Serial number 99126617
- Filing date Apr 8, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99126618 - MIIZOEY
- Serial number 99126618
- Filing date Apr 8, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99126631 - VYSTREMII
- Serial number 99126631
- Filing date Apr 8, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations

Bristol-Myers Squibb Company

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Metabolic enzyme activity and disulfide bond reduction during prote...

Methods for regenerating chromatography resins

Substituted amide compounds useful as farnesoid X receptor modulators

Methods of AAV therapy

Antibodies against TIM3 and uses thereof

Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inh...

Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4...

Antibody comprising a glutamine-containing light chain C-terminal e...

Galectin-3 inhibitors

Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-...

Small molecule inhibitors of galectin-3

Tricyclic heteroaryl compounds useful as IRAK4 inhibitors

Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use th...

Indicating differences in and reconciling data stored in disparate...

Pyrrolidinone derivatives as formyl peptide 2 receptor agonists

Small molecule inhibitors of galectin-3

Small molecule inhibitors of galectin-3

Indazole carboxamides as kinase inhibitors

Small molecule inhibitors of galectin-3

Small molecule inhibitors of Galectin-3

Process for the preparation of a cyclic dinucleotide

Nucleic acids encoding modified FGF-21 polypeptides, vectors and ce...

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Amide-substituted heterocyclic compounds for the treatment of condi...

Method of controlling the pink color generated during antibody manu...

Methods of decreasing the galactose content of a recombinant glycop...

Piston valving for serially connectable drug modules of a combinato...

Substituted bicyclic compounds as farnesoid X receptor modulators

FGF-21 formulations

Combination of TIM-4 antagonist and PD-1 antagonist and methods of use

Patents Applicationslast 30 patents

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

TRANSIENT EXPRESSION OF THERAPEUTIC PROTEINS

COMBINATION THERAPY FOR COLORECTAL CARCINOMA

SUBSTITUTED IMIDAZOPYRIDINYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9

INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...

TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS

METHODS OF PRODUCING RECOMBINANT PROTEINS

Machine-Learning Models for Prognosing Outcomes For Hypertrophic Ca...

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9

COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TR...

SUBSTITUTED HETEROCYCLIC COMPOUNDS

MACROCYCLIC IMMUNOMODULATORS

KRAS INHIBITORS

Compounds and Their Use for Treatment of Hemoglobinopathies

COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A...

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METH...

CYTOKINE PROFILING ANALYSIS

COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANT...

METHODS TO MANIPULATE QUALITY ATTRIBUTES OF POLYPEPTIDES PRODUCED I...

TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBO...

METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN...

KRAS INHIBITORS

MACROCYCLIC PEPTIDES USEFUL AS MODULATORS OF TNF ALPHA

TREATMENT OF RENAL CELL CARCINOMA

UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS

METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY

TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

INDICATING DIFFERENCES IN AND RECONCILING DATA STORED IN DISPARATE...

Trademarklast 30 trademarks

99169291 - OPDUALAG QSONI

99165576 - OPDUALAG QSOVE

99165581 - OPDUALAG QUFECTO

99165591 - OPDUALAG QFECTO

99165552 - QSISTEN

99165553 - QSONI

99165556 - OPDUALAG QSIST

99165548 - QBYON

99165550 - OPDUALAG QSISTEN

99165602 - OPDUALAG QLESK